We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Aptose to Present at the RBC Capital Markets 2015 Global Healthcare Conference

News  
Published: February 20, 2015 
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above. ✖

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

By submitting your email address, you agree to receive email communications related to Technology Networks content, products, or our partners. You may unsubscribe from these communications at any time as we respect your privacy. View our Privacy Policy for more information.
Read time: Less than a minute

Aptose Biosciences Inc. has announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, will present at the upcoming RBC Capital Markets 2015 Global Healthcare Conference on Tuesday, February 24th at 1:35 p.m. ET at the Kennedy 1 Room at the New York Palace Hotel in New York City.

Dr. Rice will provide a corporate overview of the Company's recent activities and strategic direction including plans to develop Aptose's lead clinical agent, APTO-253 for acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and other hematologic malignancies.

A live audio webcast of the Aptose presentation will be accessible by visiting: http://www.veracast.com/webcasts/rbc/healthcare2015/84110376508.cfm.

Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter